FDA 510(k)

应用生物系统™ TaqPath™ COVID-19诊断PCR套件

K号: K233453 · 2024-07-10

决定日期2024-07-10

产品代码QQX

咨询委员会抱歉，您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is the device name listed in this FDA 510(k) record. The listed applicant is Life Technologies Corporation. It received FDA 510(k) clearance on 2024-07-10 under 510(k) number K233453. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is a medical device that received FDA 510(k) clearance on 2024-07-10. The listed applicant is Life Technologies Corporation. The 510(k) number is K233453.

When did Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit receive FDA 510(k) clearance?

Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit received FDA 510(k) clearance on 2024-07-10, under 510(k) number K233453.

Who is the listed applicant for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

The FDA 510(k) record lists Life Technologies Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit?

The FDA product code for Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR Kit is QQX.

列明Life Technologies Corporation为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K241806应用生物系统™ TaqPath™ COVID-19、流感A、流感B、RSV选择面板 K191030应用生物系统™ 3500 Dx遗传分析仪和应用生物系统™ 3500xL Dx遗传分析仪 K170299离子PGM Dx系统

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。